Medable gets an opportunity to simultaneously improve clinical care and advance clinical research in collaboration with the American Heart Association
Image: The Human Heart Digitome will be a research resource to all stakeholders in the cardiovascular disease community. Photo: Courtesy of Bokskapet from Pixabay.
Medable the leading provider of digitally enabled and data-driven clinical trials, will join the American Heart Association’s Center for Health Technology & Innovation Innovators Network. The Center is focused on building health-tech relationships to drive innovative and scalable solutions across the health continuum.
The Center helps members of its Innovators Network in the healthcare technology field align and integrate their technology with the Association’s digital resources to encourage the development and adoption of digital healthcare solutions.
Medable joins the Innovators Network to meaningfully advance the understanding and treatment of cardiovascular disease. The collaboration will help enhance a patient-centric digital, real-world evidence research network that connects patients and researchers. The platform will seek to dramatically improve patient care by providing patients with the Center’s health management plans (called, CarePlans) in a seamless and personalized digital experience while advancing research by capturing patient reported, connected device, EMR, and clinical outcomes assessment data.
The data collected will be made available to patients and collaborating researchers in the Human Heart Digitome, powered by Medable’s analytics system that provides intelligence across the various types of health data. The collaboration aims to develop the largest digital real-world evidence data set to advance the understanding and treatment of cardiovascular disease.
Collaborating with the American Heart Association, Medable has a very important opportunity to simultaneously improve clinical care and advance clinical research. Registry participants will receive the best in clinical guidance with personalized digital CarePlans while advancing research through secure patient-governed data generation on the Medable platform. The Human Heart Digitome will be a research resource to all stakeholders in the cardiovascular disease community.
“The Human Heart Digitome, a digital real-world evidence patient registry created on Medable’s end-to-end platform, will enable physicians and researchers to better identify at-risk patients using Medable’s predictive analytics platform, improve health outcomes and bring new cardiovascular therapies to patients faster,” said Dr. Michelle Longmire, CEO & co-founder of Medable.
Source: Company Press Release.